OncoCyte Corporation, Cornell University License Agreement to Accelerate Lung Cancer Diagnostic Product Development

News   May 27, 2014

 
OncoCyte Corporation, Cornell University License Agreement to Accelerate Lung Cancer Diagnostic Product Development
 
 
 

RELATED ARTICLES

An Artificial Mole As An Early Warning Sign

News

ETH researchers have developed an early warning system for the four most common types of cancer. Should a tumour develop, a visible mole will appear on the skin.

READ MORE

Liquid Biopsy Developed for Multiple Myeloma

News

Chip-based blood test for multiple myeloma could make bone biopsies a relic of the past.

READ MORE

A New, Streamlined Approach to Diagnosing and Treating Bowel Cancer

News

Researchers at the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide have discovered a faster, more cost-effective way to determine which DNA mutations cause human bowel cancer.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE